It seems likely that MACC1 and S100A4 also cooperate in other cancer entities, as the two biomarkers were described for improved prognosis of ovarian or gastric cancer, which underlines its considerable cross-entity potential [35, 36]. Here, MACC1 is linked to gastric cancer.